On-Demand: Physician Views: Developing Treatments for NASH

June 28, 2018

Several drug companies are developing treatments for Non-alcoholic Steatohepatitis (NASH). We recently surveyed US physicians to find out how they are treating patients and comorbid conditions—and what they would like to see in a regimen.

In this on-demand webinar we hear Molly Simpson, InCrowd’s Director for Client Engagement, discuss the key findings.

Watch now!

  • This field is for validation purposes and should be left unchanged.